Theophylline/ephedra/hydroxyzine

Theophylline/ephedra/hydroxyzine
Combination of
Theophylline	Stimulant
Ephedra (medicine)	Stimulant
Hydroxyzine	Antihistamine
Clinical data
Trade names	Marax
AHFS/Drugs.com	Micromedex Detailed Consumer Information
Routes of; administration	By mouth
ATC code	R03DA74 (WHO) ;
Identifiers
CAS Number	64095-02-9;
PubChem SID	135272520;

Theophylline/ephedra/hydroxyzine (trade name Marax) is a drug that was used for the treatment of asthma. It was a combination of theophylline, ephedra,[1] and hydroxyzine, and taken by mouth.[2][3] It is no longer manufactured in the US due to ephedra being removed from approval by the FDA.

References

Hunt TM (2011). Drug Games: The International Olympic Committee and the Politics of Doping, 1960–2008. University of Texas Press. p. 45. ISBN 978-0-292-73957-4. Retrieved 20 July 2018.
Marax Micromedex Detailed Consumer Information. Accessed 23 April 2021.
Fixley M, Shen DD, Azarnoff DL (June 1977). "Theophylline bioavailability: a comparison of the oral absorption of a theophylline elixir and two combination theophylline tablets to intravenous aminophylline". The American Review of Respiratory Disease. 115 (6): 955–62. doi:10.1164/arrd.1977.115.6.955 (inactive 1 August 2023). PMID 262107.{{cite journal}}: CS1 maint: DOI inactive as of August 2023 (link)

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

[1] Hunt TM (2011). Drug Games: The International Olympic Committee and the Politics of Doping, 1960–2008. University of Texas Press. p. 45. ISBN 978-0-292-73957-4. Retrieved 20 July 2018.

[2] Marax Micromedex Detailed Consumer Information. Accessed 23 April 2021.

[3] Fixley M, Shen DD, Azarnoff DL (June 1977). "Theophylline bioavailability: a comparison of the oral absorption of a theophylline elixir and two combination theophylline tablets to intravenous aminophylline". The American Review of Respiratory Disease. 115 (6): 955–62. doi:10.1164/arrd.1977.115.6.955 (inactive 1 August 2023). PMID 262107.{{cite journal}}: CS1 maint: DOI inactive as of August 2023 (link)